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In the search for mechanisms underlying the detrimental influence of the aging 
process on the functions of the nervous system, the progressive derangement of 
intracellular calcium homeostasis has gained increasing attenti0n.l" Changes in cal- 
cium homeostasis during aging are considered to lead to a gradual but chronic Ca2+ 
overload with serious consequences for neuronal excitation and cellular communi- 
cation?" 
In contrast to extensive knowledge on altered [CaZ+] in the cellular and extracellular 
components of the cardiovascular system during aging,5 such information on cerebral 
vasculature is scarce. The total free [Ca'+] in major cardiac and body arteries show 
a dramatic, progressive increase in an age-dependent fashion, which is accelerated 
by risk factors like nicotine, diabetes, and hypertension.6 
Like the peripheral vessels, however, the vasculature of the brain is prone to 
considerable pathological changes during the aging which are apt to exert 
a profound influence on the neuronal functions of the brain.9 Because the blood- 
brain barrier (BBB) limits free entry of nutrients and metabolites from the blood 
stream to the parenchyma, the condition and integrity of the cerebral microvascular 
system may have a profound impact on general neuronal activity and the nervous 
control of behavioral functions.'0 As such, the causal mechanism of behavioral impair- 
ment as a consequence of aging may be regarded as being one of the key questions 
in aging research. The importance of the BBB for brain functioning prompted us to 
study the consequences of the aging process with specific interest in the relation 
between vascular, neuronal, and behavioral parameters. 
bAddress for correspondence: Dr. P. G. M. Luiten, Department of Animal Physiology, University 
of Groningen, Kerklaan 30, 9751 NN Haren, the Netherlands. 
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In the homeostatic regulation of intracellular free calcium [Ca2'], various mecha- 
nisms are involved that interact in a complex fashion. Free intracellular Ca" is the 
result of a balance between receptor-, channel-, and electric potential related Ca2+ 
influxes, intracellular release mechanisms, buffering by Caz' binding proteins, intracel- 
lular uptake and storage, and efflux by ion exchange and ion pumps.'' 
In the search for tools to antagonize the chronic elevation of [Caz+], associated 
with brain aging, it has become a promising strategy to limit Ca" influx by blockade 
of Ca2' entry pathways." Nimodipine, a lipophilic dihydropyridine acting as an L- 
type channel Ca2' antagonist, easily crosses the membranes of the BBB, and this 
way has ready access to intra- and extracellular components of neuronal, glial, and 
vascular domains of the nervous system. Evidence has accumulated in recent years 
that blockade of Ca2+ influx via L-type channels with this compound exerts powerful 
effects on neuronal: cerebrova~cular,'~ and behavioralI4 alterations in aging mammals. 
Nimodipine was demonstrated to enhance neuronal excitability and improve behav- 
ioral and cognitive performance in senescence in several mammalian species including 
man.15J6 These nimodipine findings together with our own experience with drug 
application on cerebrovascular condition prompted us to investigate effects of chronic 
application of this drug on some vascular, neuronal, and behavioral characteristics 
of aging normotensive rats. 
The nimodipine effects in normotensive animals were extended with studying 
the influence of this drug in aging hypertensive stroke-prone rats. Hypertension is 
considered a pathological condition that during aging poses an additional risk factor 
for the development of cardiovascular and cerebrovascular infarctions and ischemia.I7 
In that sense hypertension may be thought to accelerate the dysfunctions and patholo- 
gies attributed to the aging process. Hypertension enhances the already dramatic 
aging-related increase of [Ca'+] in the vascular tissue in several vessels of the peripheral 
arterial system, pointing to a common mechanism in disturbance of Caz+ homeostasis. 
Hypertension not only affects peripheral vessels, but also threatens cerebral vascula- 
ture in senescence when stroke and edema may de~elop .~ . '~- '~  The fact that hypertension 
accelerates [Ca2+] in the vascular wall in the course of the aging process suggests 
that aging and hypertension share common mechanisms of altered Ca2+ homeostasis. 
For that reason it became interesting to establish the influence of the CaZt entry 
blocker nimodipine in aging hypertensive rats. 
EFFECTS OF NIMODIPINE IN AGING NORMOTENSIVE RATS 
When investigated by electronmicroscopy, a large variety of alterations can be 
observed in the brain of the aging mammal. In senescence changes occur in essentially 
all cellular and extracellular components of the brain such as nerve cells, various 
glial cell types, and cerebrovascular cells. As described by many investigators, these 
changes include the gradual accumulation of lipofuscin (FIG. 1 A), excessive myelin 
breakdown by oligodendrocytes, neuronal degeneration (FIG. lB), synaptic reorgani- 
zation and glial hypertrophy, and degenerative changes of the vascular wall. Notably 
the latter category of vascular breakdown was studied in greater detail with specific 
interest for the progressive course of events and the influence of chronic treatment 
with nimodipine on this vascular degenerative process. 
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FIGURE 2. Cortex of rat aged 30 months. (A) Appearance of perivascular deposits consisting 
of a dense amount of banded collagen fibrils (c). The vascular lumen is lined by the endothelium 
(e) containing several large vacuoles, but with an intact tight junction. Astrocytes are hypertro- 
phied (as). (B) Thickening of basement membrane (*) as a form of perivascular deposition. 
Scale bar = 1 pm. 
Aging, Nimodipine, and Microvascular Morphology 
This study was focused on the integrity of the microvessels as they comprise the 
anatomical substrate of the BBB. As reported in a sequence of papers, several 
structural alterations occur in senescence such as stages of degeneration of pericytes” 
and a series of infrequent anomalies and depositions of collagen-like and collagen- 
derived components in the microvascular wall designated as fibrosis and basement 
membrane thickening7**~*’ (FIG. 2). It is notably the perivascular deposit, which, 
throughout the lifespan of the Wistar rat of approximately 32 months, is subject to 
a prominent influence of treatment with the calcium blocker nimodipine. In aging 
control animals the incidence of perivascular deposits gradually increases up to the 
age of 30 months and then levels off over 30 months in the parietal motor cortex.I3 
During the latter final life stage the nature of the deposits changes from an obvious 
collagen fiber appearance to an amorphic bed of perivascular basement membrane 
thickening most likely a result of molecular depolymerization.” During the aging 
process we treated groups of Wistar rats chronically with an optimal dose of 1,000 
ppm nimodipine administered via their daily food intake. The drug effects were 
studied after several treatment periods from 16-30 months, 24-30 months, and 24- 
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FIGURE 3. Diagram with the development of perivascular deposits during the lifespan of 
Wistar rats up to the age of 32 months. Note that the gradual increase during aging levels off 
at ages over 30 months. Treatment with the Ca2+ antagonist nimodipine from 16-30 months 
suppresses the formation of the deposits, as it does from 24-30 months. Over the age of 30 
months drug treatment becomes ineffective. 
32 After all treatment periods the incidence of perivascular deposits was 
significantly suppressed except for the final life phase over 30 months. Here we 
observed that further treatment could no longer delay the malformations of the 
perivascular wall (FIG. 3). The treatment effects were proportional to the duration of 
treatment and the starting point of nimodipine application. More detailed analysis of 
the deposits in the microvascular wall revealed the collagen fibrotic nature of the 
perivascular malformation, which is characterized by typical banded fibrils with a 
periodicity of 64 nm. An important observation from a functional point of view was 
the apparent endothelial origin of the fibrosisI3 (FIG. 4A). In several instances collagen- 
like fibrils could be detected within the endothelial vacuoles or cytoplasm, whereas in 
the region with the thickened basement membrane often large amounts of pinocytotic 
vesicles occurred indicative of abnormal transport processes over the BBB (FIG. 4B). 
At the same time the affected microvessel was surrounded by enlarged astrocytic 
endfeet. The complex of aberrant microvascular structure may well be interpreted 
as the morphologic basis of dysfunctions of the BBB that coincide with the decreased 
BBB transport capacity during (FIG. 5). The aforementioned observations 
were made on the parietal cortex as a representative of forebrain cortical structures. 
Sample studies on hippocampus and spinal cord indicate that the aging-related vascular 
decline and the nimodipine effects were basically similar in these structures of the 
central nervous system. The spinal effects, however, were of a lower magnitude, 
which may be related to the lower density of L-type Ca2+ channels in the brainstem 
and spinal cord.% 
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FIGURE 4. (A) Short collagen fibril fragment (arrowhead) in the cytoplasm of the endothelial 
cell (e). (B) Occurrence of large number of pinocytotic vesicles (arrows) in the endothelial 
cell of a microvessel in the cortex of an aged (30-month-old) rat. Within the basement membrane 
the collagen fibrils are deposited, while the astrocytic endfeet are enlarged. Scale bar = 0.5 
Pm. 
Aging, Nimodipine, and Synaptic Ultrastructure 
Apart from the vascular changes in aging animals, a variety of neuronal changes 
also were recorded. In more detail we established the impact of the calcium antagonist 
neuropil 
FIGURE 5. Schematic impression of lo- 
cal perivascular deposits in microvessel 
walls in the aging brain. The impact of 
microvascular aberrations is indicated by 
the arrows that represent dysfunction of 
the blood-brain barrier and its influence on 
the surrounding neuropil. 
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on the synaptic density and size exemplified on the supragranular layer of the dentate 
gyrus. This region was selected because of the general consensus that in this region 
the number of synapses is decreased in aged mammals including man in health and 
d i s e a ~ e . * ~ - ~ ~  The synaptic changes during aging were assessed with the ethanolic- 
phosphotungstic acid method which selectively stains for synaptic structures for 
electron microscopic application. Our observations were in line with the reports of 
others that the synaptic density expressed as the number of synapses per cubic 
millimeter significantly decreased by a fourth.3o Although the average synaptic surface 
did not change, the decrease in density coincided with a very significant decline in 
total synaptic surface area. The effect of nimodipine treatment became prominent in 
both density and total synaptic surface parameters, such that the decline in density 
was entirely prevented by the drug, while the synaptic surface was significantly 
higher than that of the untreated age-matched controls. In summary, these nimodipine 
effects may be interpreted as a long-term counteractive effect on the age-dependent 
decline of the synaptic structure in this part of the hippocampus. 
Aging, Nimodipine, and Calcium Binding Proteins 
Inasmuch as the currently used calcium antagonist exerts such a profound influence 
on neuronal structure and function, we included some calcium-related parameters of 
aging neurons. As one parameter that is of potential importance for calcium homeo- 
static mechanisms, we investigated the immunoreactivity (ir) of calcium-bound forms 
of calcium binding proteins during aging in rabbit and rat?' In rabbit dentate gyrus 
the calbindin-D28k (CaB) protein showed a striking decline during the fmst 12 months 
of the rabbit's lifespan after which the CaB-ir level remained constant up to the age 
of 48 months (FIG. 6). Between 48 and 60 months a second phase of CaB decline 
was observed when CaB-ir reached a level of about 25% of the optical density of 
1 -month-old animals. This age-dependent decrease of CaB-ir was essentially similar 
for granule cells, their dendrites in the dentate molecular layer, and the mossy fiber 
projection to the CA3 region. A similar trend was found for CaB-positive cells in 
the CA1 pyramidal cell layer, but not in the stratum oriens. In the rabbit, age had 
no effect on the numbers of parvalbumin-positive GABAergic neurons in the various 
regions of the cornu ammonis. 
In the rat, CaB-ir strongly declined in senescence to a similar degree as in rabbit 
notably in the dentate gyrus and the neocortex (FIG. 7), but not in the CA1 of the 
hippocampus. As in the rabbit the number of parvalbumin-positive cells did not 
change in cortex and hippocampus. In rat we also investigated if the CaB and PARV 
pattern changes were influenced by chronic nimodipine treatment. Chronic treatment 
with the calcium antagonist only moderately antagonized the decline of the two 
calcium binding proteins investigated. Only in the cortex was the reduction of CaB 
attenuated, and this was significant in the parietal cortex (FIG. 7). 
Aging, Nimodipine, and Open-Field Behavior 
There are numerous reports on the impact of calcium channel blockers on various 
behavioral parameters. (See the contributions of Traber and Fannelli, this volume.) 
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FIGURE 6. Calbindin D28k immunoreactivity (CaB-ir) in the various layers (granule cell 
layer, gran; inner molecular layer, mol.1; outer molecular layer, 11101.2) of the dentate g y m  at 
eight different ages in the rabbit. Immunoreactivity was quantified with image analysis. Values 
were calculated as a percentage of the highest value of 1-month-old rabbit, which was set at 
100%. The CaB-ir rapidly declines during the first 12 months, stabilizes up to 48 months, and 
is followed by a final reduction in extremely aged cases of 60 months. 
motor cx par cx 
0 young aged aged-nimo 
FIGURE 7. CaB immunoreactivity measured by optical density image analysis and expressed 
as percentages in layers 11-IV of parietal and motor cortex in young (3-month-old), aged (30- 
month-old), and aged (24- 30-month-old), nimodipine-treated Wistar rats. The sharp decrease 
in CaB-ir in the aged rat is slightly attenuated by nimodipine treatment, which was significant 
in the parietal cortex (**p < 0.01; "p < 0.05). 
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In short, these studies demonstrate that chronic nimodipine application improves 
behavioral scores in motor performance and spatial memory, facilitates and accelerates 
learning and conditioning, improves short-term memory in the radial maze, and 
attenuates the age-related decline in visual Also the first trials in 
humans with various types of dementia point to improved neuropsychological scores 
and a prophylactic effect on the progression of the dementing p roce~s . '~~ '~  
In the same animals used to investigate cerebrovascular and neuronal effects, we 
also assessed the behavioral scores in a novelty-induced behavioral arousal paradigm 
(FIG. 8). In this test the spontaneous behavior of young (3 months), aged (30 months), 
and aged, nimodipine-treated rats (24-30 months) was recorded during 60 minutes. 
Aged animals of 30 months compared to 3-month-old controls were characterized 
by a very significant suppression of exploration, rearing, walking, and sniffing accom- 
panied by an equally large increase in immobility. All these age-dependent spontane- 
ous behavioral expressions were significantly antagonized in a dose-dependent manner 
by chronic nimodipine application starting at the age of 24 months16 (FIG. 8B). The 
observed behavioral effects of the aging process (as in the small open field test in 
aging) and the impact of nimodipine both corroborate the effects of this drug in 
motor and cognitive behaviors as reported by others in various s p e ~ i e s . ' ~ * ' ~ , ~ ~ - ~  
Summary of Nomotensive Brain Aging 
Aging in the rodent, as in other mammalian species, reveals a wide variety of 
cerebrovascular, neuronal, and behavioral changes that collectively represent a slow 
I , 1 1 1  lU.I .2 
FIGURE 8. (A) Immobility scores measured during 60-minute observation of rats exposed 
to novelty-induced behavioral arousal in an open field test. Young animals show a lower level 
of immobility than do aged animals. The immobility of the nimodipine group (24-30 months 
of treatment) was significantly lower than that of the age-matched controls. (B) The reversed 
effects are seen by scores of head movements as a measure of exploratory behavior in the open 
field. Nimodipine effects are dose-dependent. 
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but gradual deterioration in the cellular components of the brain, its blood supply, 
and BBB, leading to deficiency of basically all behavioral performance. In a series 
of investigations we demonstrated a significant effect of the L-type calcium channel 
blocker nimodipine on a number of microvascular, synaptic, and behavioral parame- 
ters. Control over calcium influx eventually will yield maintenance of microvascular 
function, control of the endothelium over BBB function, improvement of astrocytic 
and glial support, and delay of neuronal breakdown and neuronal signal transduction. 
The mechanism by which a compound such as nimodipine affects the aging process 
as yet remains a subject of study. Convincing evidence exists that aging affects 
several aspects of calcium-regulating homeostasis. More recent studies establish the 
notion that aging burdens the cell with a persistent overload of basal [Cali levels and 
delays the mechanisms that restore intracellular calcium  concentration^.'^^^^ Convinc- 
ing electrophysiological  report^^,^ indicate that a compound such as nimodipine attenu- 
ates the prolonged afterhyperpolarization in aging hippocampal pyramidal neurons, a 
phenomenon that is associated with improved behavioral conditioning by nimodipine! 
The way in which nimodipine exerts such a powerful effect in delaying the 
deterioration of the microvascular wall during aging remains unclear. The aberrant 
microvessels in the aging rat brain are often circumvented by hypertrophied astrocytes. 
Because astrocytes play an important role in the maintenance of the BBB, these 
observations suggest that a loss of cerebrovascular integrity induces BBB alterations. 
More specifically, the increased number of pinocytotic vesicles in the endothelial 
cytoplasm in compromised microvessels points to disturbed nutrient transport over 
the microvascular wall. Such impaired BBB transport function has been demonstrated 
in the aging CNS'0.23.x~37 and clearly affects the surrounding neuropil and subsequent 
neuronal functioning. 
On first sight, the percentage of microvessels displaying microvascular deposits 
may seem relatively small. However, each microvessel probably will contain several 
anomalies along its longitudinal surface, so that examination of microvascular cross- 
sections provides the relative density of these aberrations. Assuming that each mi- 
crovessel in the aging brain displays loss of integrity and concomitant impaired 
nutrient transport along its surface, the devastating implications for neuronal function- 
ing become clear (FIG. 5). In this light we can consider the protective effect of chronic 
calcium channel blockade (50% fewer microvessels with deposits in animals aged 
up to 30 months) as highly beneficial. Moreover, the fact that a calcium antagonist 
can be so effective implicates that disturbed calcium homeostasis of the microvascular 
wall strongly contributes to aging-related impaired neuronal functioning and conse- 
quent behavioral performance. 
Most evidence points to the endothelial cell as the main origin of microvascular 
deterioration during aging. Not only are the number of endothelial pinocytotic vesicles 
increased in the aging brain, but also small collagen fibrils are present within the 
endothelial cytoplasm of aberrant microvessels. The cerebrovascular effects of cal- 
cium antagonists were thus far explained by vasodilatory influences on larger vessels, 
but never anticipated the presence of L-type calcium channels in endothelial cells. 
In contrast to those in the peripheral circulation, the larger arteries in the CNS are 
major determinants of local microvascular pressure.38 Our studies cannot exclude that 
the beneficial influence of calcium channel blockade on microvascular integrity in 
the aging brain is secondary to alterations in the larger resistance vessels. When 
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larger blood vessels in the brain dilate under the influence of nimodipine, the microvas- 
cular blood pressure will be reduced, possibly preventing the formation of microvascu- 
lar aberrations. However, all the ultrastructural evidence for endothelial involvement 
in microvascular deterioration during aging and the influence of calcium channel 
blockade lead to an alternative hypothesis. Although most studies indicate that Ca2+ 
enters endothelial cells through nonselective cation  channel^,^'.^^ Bossu and cowork- 
em4' demonstrated the presence of L-type calcium channels in isolated capillary 
endothelial cells. We now hypothesize that increased calcium influx through L-type 
calcium channels in the endothelial cell contributes to the declined microvascular 
condition and subsequent impaired neuronal functioning in the aging CNS (FIG. 12). 
EFFECTS OF NIMODIPINE ON AGING SPONTANEOUSLY 
HYPERTENSIVE STROKE-PRONE RATS 
General Condition and Occurrence of Stroke 
High blood pressure is now commonly regarded as the most frequently occurring 
risk factor in vascular pathology in the peripheral circulation. Analysis of coronary 
and larger arterial tissue reveals high blood pressure as a major contributor of Ca2+ 
accumulation in the vascular wall notably combined with aging.6 Little is known 
about the influence of elevated blood pressure and aging on Ca2+ contents in the 
cerebral vasculature. On the other hand, there is well documented evidence for the 
acute effects of the Ca antagonist nimodipine on the vasodilatory characteristics of 
the cerebral vasculature,"' which is probably mediated via the smooth muscle cells 
of the larger vessels. Here we investigated the impact of the Ca2+ entry blocker in 
aging spontaneously hypertensive stroke-prone (SHR-SP) rats, in which the effects 
of chronic drug application were assessed on a number of vascular, physiological, 
neuronal, and behavioral parameters. The influence of high blood pressure on the 
aging process became readily obvious as the hypertensive strains showed all signs 
of aging-related deterioration in body condition and behavioral performance at rela- 
tively very early stages of life as compared to normotensive Wistar-Kyoto (WKY) 
animals. In a first set of experiments SHR-SP rats were chronically treated with 
nimodipine applied via daily food intake at a concentration of 1,000 ppm starting at 
the age of 46 weeks (immediately before the period of stroke development) up to 
the age of 56 weeks. During the treatment period the physical condition (fur condition 
and locomotor activity) gradually deteriorated. The body weight of the placebo- 
treated SHR-SP animals decreased from 330 to 280 g, whereas the nimodipine-treated 
group (SP-nimo) remained at a consistently higher level and even showed a slight 
increase from 323 g to an average of 354 g. No effects of treatment were found in 
age-matched normotensive WKY rats (TABLE 1). Furthermore, during the 10-week 
treatment all SP-placebo rats developed neurologic (irritability and paralysis) and 
histologic signs of stroke, but none of the SP-nimo cases did. In fact, because of the 
increasing number of lethal SP-placebo cases, the treatment period had to be termi- 
nated to maintain a sufficient number of placebo cases for statistical analysis. All of 
the 11 SP-nimo animals survived the experimental period, whereas 4 of 11 SP- 
placebo rats died with the symptoms of stroke. The incidence of stroke at the end 
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TABLE I. Effect of Treatment on the Occurrence of Neurologic and Histologic 
Signs of Stroke, Body Weight, and Brain Weight in Spontaneously Hypertensive 
Stroke-Prone (SHR-RP) Animals at the Start of the Experiment (Onset) and after 
10 Weeks of Treatment with Nimodipine Food (1,000 ppm) or Placebo Food 
Rats 
Age with Body Weight Brain Weight 
Group (wk) Stroke (g) (g) 
SHR-SP onset (5) 46 2 330 i 15.6 2.04 f 0.20 
SHR-SP nimo (7) 56 0 354 i 7.1** 1.81 * 0.02 
SHR-SP plac (7) 56 7 281 * 9.3* 2.53 i 0.11** 
NOTE: Significantly different from onset group at *p < 0.05; ** p < 0.001. 
of the experimental period was accompanied by the presence of severe brain edema 
in the SP-placebo rats. The edema became apparent from the heavily swollen brain 
immediately after removal from the skull and was quantitatively expressed by the 
significant increase by 40% in brain weight in the SP-placebo versus the SP-nimo 
animals (TABLE l), whereas the body weight of the SP-placebo group significantly 
decreased. It is important to note that the prevention of stroke by nimodipine could 
not be attributed to a blood pressure decrease by the drug. Nimodipine had no effect 
on the very high pressure of the SHR-SP animals and even appeared to stabilize the 
blood pressure at a value of 220 mm Hg (FIG. 9). 
300 r 
1 
46 48 50 52 i4 58 
AGE ( in weeks ) 
FIGURE 9. Development of blood pressure (BP) in spontaneously hypertensive stroke-prone 
(SHR-SP) and control Wistar Kyoto (WKY) rats treated with nimodipine or placebo food. In 
neither the WKY nor the SHR-SP group did nimodipine lower BP values. In the SHR-SP cases 
nimodipine appeared to stabilize the high BP levels. 
LUITEN et aL: CAI' CHANNEL BLOCKADE 443 
Stroke, Hippocampal Alterations, and Behavioral Dysfunction 
A major finding in the first series of experiments with SHR-SP animals was the 
neurochemical changes that occurred in the hippocampal cell groups in animals that 
had neocortical strokes. Apparently as a neuropathological consequence of cortical 
strokes, hippocampal pyramidal neurons revealed abnormally enhanced immunoreac- 
tivity for protein kinase Cy, whereas the GABA synthesizing enzyme GAD and its 
colocalized calcium binding protein parValbumin in the GABAergic interneurons 
were significantly de~reased.'~ Taken together, these stroke-induced alterations were 
interpreted as GABAergic cell degeneration leading to abnormal disinhibition of the 
pyramidal cell group. The lack of inhibition or chronic overstimulation of the pyrami- 
dal cells then would yield an abnormally high level of PKCy-ir, probably mediated 
by relatively high activation of G-protein-coupled receptor types. These changes in 
the neurochemical nature of hippocampal cell groups did not occur in the aging S H R -  
SP animals that were treated for 10 weeks with nimodipine and that were free of 
strokes. The patterns of PKCy, parvalbumin, and GAD immunoreactivity of the SP- 
nimo animals were basically similar to those in the control WKY rats. 
Before sacrifice the SP-nimo and SP-placebo animals were tested for their novelty- 
induced behavioral arousal in an open-field task. In this test condition the time the 
animals spent on exploration of their new environment was recorded and revealed 
an almost threefold higher level of activity of the SP-nimo group than of the stroke 
victims of the SP-placebo group.I9 It may therefore be concluded that the occurrence 
of stroke and the concurrent pathological condition of the hippocampal circuitry in 
these animals coincides with near total absence of behavioral arousal. 
It remained to be determined, however, if maintenance of the normal hippocampal 
and behavioral features in the SP-nimo cases was the result of prevention of stroke 
by nimodipine or a direct neuronal effect of nimodipine in aging hypertensive condi- 
tions. In other words, what is the behavioral profile and the condition of hippocampal 
neuronal parameters in aging SP rats before the development of stroke. For these 
reasons we performed a second series of experiments in which WKY and SHR-SP 
rats were tested and treated with the calcium antagonist nimodipine. Animals of the 
second experiment revealed a somewhat lower blood pressure level of around 180 
mm Hg (220 mm Hg in the first experiment) in which the symptoms of stroke started 
to appear at the age of 50 weeks (compared to 42 weeks in the first experimental 
group). Nimodipine was administered from 40-60 weeks to both WKY normotensive 
controls and SHR-SP rats. During this treatment period none of the WKY animals 
and SP-nimo rats died, whereas only 50% of the animals in the placebo SHR-SP 
survived (TABLE 2) .  None of the remaining SP-placebo rats showed neurological or 
histological signs of cerebrovascular strokes. This is also reflected by the similar 
brain weights of all SHR-SP groups and thus by the lack of brain edema formation 
(TABLE 2) .  Also the general condition and body weight of the SP-placebo rats did 
not decline during the observation period. As in this first experiment nimodipine did 
not diminish blood-pressure in normotensive WKY and hypertensive SHR-SP rats 
(TABLE 2). 
In the experimental setup we followed the behavioral scores in the open field 
test over the animals' lifespan from 12-60 weeks. It was previously shown by others 
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FIGURE 10. (A) Behavioral scores of novelty-induced exploration activity in an open field 
in the lifespan of SHR-SP animals compared with age-matched WKY controls. The initial 
hyperarousal and hyperactivity expressed by rearing of the animals are reversed to an almost 
lack of activity in the accelerated aging period of the SHR-SP group. (B) SHR-SP rats treated 
with nimodipine from 40-60 weeks show a significantly higher level of novelty-induced arousal 
than do the SHR-SP animals receiving placebo. 
controls,43*44 which corroborates our data in which young SHR-SP rats (12 weeks of 
age) displayed significantly more rearing behavior than did WKY controls (FIG. 10A). 
It is generally accepted that especially rearing as a component of exploratory behavior 
declines rapidly with advancing age. Despite the higher rearing scores at young age, 
the older SHR-SP animals (40 and 60 weeks of age) show significantly less rearing 
behavior in the open field than do WKY controls (FIG. 10A). These data indicate 
that aging-related behavioral alterations occur earlier in genetically hypertensive rats. 
Nimodipine treatment from 40-60 weeks of age increased the rearing scores, even 
when compared to that in animals aged 40 weeks (FIG. 10B). In other words, nimodi- 
pine completely counteracted the accelerated behavioral decline in aging hypertensive 
rats before they developed neocortical strokes. 
In a recent pilot experiment we compared the performance of older nonsymptom- 
atic SHR-SP rats (40 weeks) with age-matched WKY rats in a holeboard spatial 
orientation learning test that requires an intact hippocampus. The holeboard contains 
16 equidistant holes in which rats were trained to learn a pattern of four baited out 
of 16 holes, after which the reference memory ratio (RMR) was calculated. At the 
age of 40 weeks the RMR of SHR-SP rats was significantly lower than that of WKY 
controls (FIG. 1 IA). The latter demonstrates that the spatial orientation capacity of 
aging hypertensive animals is reduced compared to that of their normotensive controls. 
Similar findings were described by Wyss et al.45 who showed early impairment of 
cognitive functioning in SHR rats. 
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FIGURE 11. Performance of SHR-SP and age-matched WKY rats at the age of 40 weeks in 
the holeboard spatial learning test. In this test the animals had to learn a random spatial pattern 
of 4 baited holes of a total of 16 holes. Reference memory scores (visits food holes + revisits 
food holes/total visits food holes and non-food holes) of the WKY rats was significantly higher 
(MANOVA, p < 0.05) than those of the SHR-SP group. (B) Twenty-four hours after completion 
of the holeboard test, learning task-induced PKCy immunoreactivity (PKC-ir) enhancement in 
the hippocampal CA1 area was quantified by optical density measurement. The PKC-irresponse 
was significantly higher in the WKY than in the SHR-SP animals, consistent with their higher 
level of performance in the holeboard. 
Previous work from our group& revealed that the immunoreactivity (ir) for PKCy 
was enhanced in columns of the hippocampal formation of mice and rats that under- 
went the holeboard task. This increased PKCy-ir was most prominent in the dendritic 
fields of the CA1 area and can be attributed to increased activation of CA1 pyramidal 
cells.& We examined PKCy-ir in the hippocampus CA1 of both SHR-SP and WKY 
animals after holeboard training by image analysis. The relative optical density was 
measured in the CAI stratum radiatum and in the lacunosum moleculare of all trained 
animals. In both areas the relative optical density of PKCy-ir was significantly higher 
in the WKY animals (FIG. 1 1B). This suggests a relation between learning performance 
in the holeboard task and PKCy-ir in the CAI, because the better learners (WKY 
animals) display a denser PKCy-ir in the dendritic fields of the CA1. However, it 
remains to be established if the difference in PKCy-ir is related to learning perform- 
ance or strain differences. However, preliminary data show that PKCy-ir does not 
differ between naive WKY and SHR-SP rats at 12 weeks of age (data not shown), 
ruling out a general strain difference. Other preliminary data show that PKCy-ir 
remains stable throughout the age of 12-40 weeks in WKY rats, and declines in 
none-stroke SHR-SP rats. The latter suggests that decreased activation of CA1 pyrami- 
dal cells, as reflected by a reduced level of PKCy-ir, in aging nonsymptomatic SHR- 
SP rats underlies the impaired learning performance of these animals. 
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SUMMARY AND CONCLUSIONS 
The pathogenesis of essential hypertension is not fully understood, but most of 
the cardiovascular, metabolic, neurogenic, and humoral abnormalities are explained 
by dysfunctions in the control of intracellular Ca2' concentrations in the cells of the 
vascular wa11.47,48 Most theories of disturbed calcium regulation focus on the calcium 
concentration within vascular smooth muscle cells:' The implications of hypertension 
for the increased calcium content of aging arteries seem to be clear, but were only 
studied in the peripheral circulation; hypertension prominently augments the aging- 
related accumulation of calcium in the vessel wall.5 
Although the contribution of calcium overload in hypertensive cerebrovascular 
damage is well it is not clear yet if hypertension per se is the main 
cause of hypertension-associated calcium-dependent cerebral damage. Thus far, the 
hypotensive effects of most calcium antagonists were extensively described, and their 
efficacy in stroke prevention was proven.""' Earlier studies indicated that chronic 
administration of nimodipine revealed a protective effect in the occurrence of strokes 
in SHR-SP rats, yielding a decreased mortality Because nimodipine did not 
lower the extremely high blood pressure of these animals,''." the mechanisms behind 
such nimodipine-induced stroke prevention may be attributed to a direct cerebrovascu- 
lar and/or neuronal action of nimodipine. 
Hypertension is generally considered a vascular pathologic condition, and most 
research has been directed towards the influences of hypertension on large peripheral 
arteries such as the aorta and coronary artery. The influence of the CNS on the 
regulation of cardiovascular system and blood pressure regulation was described in 
detail, and the role of the CNS in hypertension also was the subject of ~tudy.4~ The 
increased risk of stroke in hypertensive subjects generated numerous studies on 
the precise nature of compromised cerebrovascular functioning under hypertensive 
conditions. 
Few data are available on Ca" alterations in cerebral neurons during hypertension. 
Honda et al.49 demonstrated that voltage-dependent Ca2+ uptake was higher in cortical 
synaptosomes from SHR than form normotensive animals and suggested that an 
important alteration in Ca2+ channel characteristics may occur in SHR brain synapto- 
somes. Although the density of L-type calcium channels was shown to be higher in 
the hippocampus of S H R  rats,50 others reported that the number of L-type calcium 
channels was significantly lower in the brain of SHR rats than WKY normotensive 
 control^.^' The latter data suggest that hypertension may be associated with similar 
alterations in neuronal calcium homeostasis as demonstrated for aging in normotensive 
s ~ b j e c t s . ~ ~ ~ ~ ~  To date little is known about the relationship between hypertension, the 
cerebrovascular condition, and neuronal functioning in the CNS. A major finding in 
these and other studies is that the hypertensive condition strongly accelerates the 
neuronal and behavioral alterations commonly associated with senescence in normo- 
tensive animals. The accelerated behavioral decline of spontaneous hypertensive 
rats45.53 indicates that hypertension also progressively affects neuronal functioning 
during aging. We anticipate that hypertension combined with aging will have a 
profound impact on the structure of the vascular wall of both larger and fine vessels 
in the brain. As such, hypertension in aging animals may considerably contribute to 
impaired neuronal functioning in such animals. We hypothesize that endothelial cell 




FIGURE 12. Survey diagram depicting the influence of the aging process and of a hypertensive 
condition on microvascular integrity and function of the endothelial lining of the microvascular 
wall. Aging and hypertension apparently mediated by Ca2+-dependent mechanisms directly 
affect the vascular condition and functioning of the blood-brain barrier. This way aging may 
indirectly influence glial and neuronal functioning. The aging process naturally exerts direct 
Caz+-mediated effects on the glial and neuronal condition as well. Together aging and hyperten- 
sion have a profound impact on all behavioral functions regulated by the nervous system. 
dysfunction (due to disturbed calcium homeostasis) is a major causal factor for the 
accelerated decline in CNS functioning in aging hypertensive subjects (FIG. 12). This 
way the efficacy of the calcium channel blocker nimodipine in stroke prevention can 
possibly be explained by maintenance of endothelial integrity and condition in aging 
hypertensive rats. The current results also allow the conclusion that maintenance of 
calcium balance, without reduction of blood pressure, is a fruitful strategy in therapeu- 
tic treatment of essential hypertension as a risk factor for brain dysfunction and 
stroke. 
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